SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022861
Filing Date
2020-05-07
Accepted
2020-05-07 16:12:54
Documents
60
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-10q_20200331.htm 10-Q 2327014
2 EX-10.2 ubx-ex102_150.htm EX-10.2 29843
3 EX-31.1 ubx-ex311_6.htm EX-31.1 19924
4 EX-31.2 ubx-ex312_8.htm EX-31.2 19842
5 EX-32.1 ubx-ex321_7.htm EX-32.1 14565
  Complete submission text file 0001564590-20-022861.txt   8276211

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ubx-20200331.xml EX-101.INS 1960390
7 XBRL TAXONOMY EXTENSION SCHEMA ubx-20200331.xsd EX-101.SCH 54421
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ubx-20200331_cal.xml EX-101.CAL 48567
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ubx-20200331_def.xml EX-101.DEF 178056
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20200331_lab.xml EX-101.LAB 411082
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20200331_pre.xml EX-101.PRE 323913
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 20856510
SIC: 2834 Pharmaceutical Preparations